IR/PR

Bio-pharm Solutions (CEO Choi Yong-moon) announced on the 30th that it signed an license deal agreement related to the technology for ‘JBPOS0101’, a candidate compound for the treatment of infantile spasms and partial onset seizure, with ‘Jingxin Pharmaceutical Co.,Ltd’, a CNS (central nervous system)  pharmaceutical company which became listed on the Shenzhen Exchange in China. […]